Cafepharma Today

June 2 2025 - Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Gilead's CAR-T cell therapy shows promise in deadly brain cancer
Sanofi expands rare immunology portfolio with Blueprint buyout
Moderna's next-gen COVID shot gets FDA backing with some limitations
BioNTech flips its cancer bispecific to BMS for a big profit
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Novartis eyes MediGene's cancer drug - sources
Hemscott, UK
Monday, September 22, 2008 - 10:45am
tags:
Decision due soon on Lilly, Daiichi blood thinner
Guardian, UK
Monday, September 22, 2008 - 10:45am
tags:
WHO concerned over plant of Novartis unit Sandoz
Forbes
Monday, September 22, 2008 - 10:44am
tags:
Strong data for Amgen's denosumab excites doctors
Pharma Times, UK
Monday, September 22, 2008 - 10:44am
tags:
Biolase: Is Turnaround Under Threat?
Seeking Alpha
Monday, September 22, 2008 - 10:43am
tags:
SciClone Provides Promising Results From Its Phase 2A Clinical Trial Using SCV-07 as a Monotherapy in Patients With Chronic Hepatitis C Infection
Yahoo
Monday, September 22, 2008 - 10:42am
tags:
Alpharma Licenses Durect's Novel Bupivacaine Patch
Yahoo
Monday, September 22, 2008 - 9:59am
tags:
Safe Havens in Large-Cap Pharma
Yahoo/Zacks.com
Monday, September 22, 2008 - 9:06am
tags:
FDA Meeting Provides Green Light for Cell Therapeutics Submission of Supplemental Filing for Zevalin(R) Label Expansion
Yahoo
Monday, September 22, 2008 - 9:05am
tags:
Sanofi Clinches Zentiva Takeover With Sweeter $2.6 Billion Bid
Bloomberg
Monday, September 22, 2008 - 9:04am
tags:
Merck KGaA's New Rebif Formulation Helps Prevent Brain Damage
Bloomberg
Monday, September 22, 2008 - 9:04am
tags:
FDA issues complete response letter to Roche for Actemra Biologics License Application
PipeLineReview
Sunday, September 21, 2008 - 4:55pm
tags:
Decision due soon on Lilly, Daiichi blood thinner
Reuters
Sunday, September 21, 2008 - 4:54pm
tags:
Teva: MS drugs continue to prove safe, effective
Globes, Israel
Sunday, September 21, 2008 - 4:52pm
tags:
Expert Says Eshoo-Barton Bill Stifles Drug Innovation, USA
Medical News Today
Sunday, September 21, 2008 - 4:50pm
tags:
More consolidation seen in generic drug industry
Chicago Daily Herald, IL
Sunday, September 21, 2008 - 4:48pm
tags:
Med Tech May Offer Investors Refuge
Yahoo
Saturday, September 20, 2008 - 11:59am
tags:
Acorda Therapeutics Presents Additional Data from Second Positive Phase 3 Study of Fampridine-SR at World Congress on Treatment and Research in Multiple Sclerosis
Yahoo
Saturday, September 20, 2008 - 11:58am
tags:
Opexa shares lose most of value on study data
Yahoo/AP
Saturday, September 20, 2008 - 11:57am
tags:
Sunesis: Publish or Perish?
Seeking Alpha
Saturday, September 20, 2008 - 11:55am
tags:

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.